Article
Case Report of COVID-19 Vaccination in a Rituximab-treated Mantle Cell Lymphoma Patient
2021-04-28
Abstract excerpt
Patients with hematological malignancy have been reported to have impaired vaccine responses. Similarly, patients with recent prior exposure to rituximab have been reported to have impaired vaccine responses. Here, we report a case of a mantle cell lymphoma (MCL) patient with recent rituximab therapy who did not have an antibody response to the BNT162b2 COVID-19 vaccine, but had a T cell response consistent with p...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d596bd25-30a7-5200-9d2e-5440740ab5f8
- DOI
- 10.2139/ssrn.3825910